Navigation Links
Lentigen to Move Headquarters and Manufacturing to Gaithersburg
Date:2/13/2008

GAITHERSBURG, Md., Feb. 13 /PRNewswire/ -- Lentigen Corporation today announced the company is moving its corporate headquarters and manufacturing facilities from the University of Maryland Baltimore County TechCenter to a new 26,000 square-foot facility in Gaithersburg.

Located along Maryland's I-270 technology corridor, the expanded facility will accommodate Lentigen's future growth needs as a leading developer and manufacturer of lentiviral vectors and proteins for a wide range of therapeutic and research applications. Two self-contained suites will allow simultaneous multi-product manufacture in compliance with FDA-regulated current good manufacturing practices and EMEA regulatory standards.

"We are very pleased to have found a facility that will meet our expansion requirements for both research-grade and clinical-grade operations," said Tim Ravenscroft, Lentigen's chief executive officer. "Located in the heart of Maryland's technology corridor, we will be well situated to attract talented individuals to our growing organization and to meet the increasing needs of our partners and customers."

About Lentigen Corporation

Lentigen Corporation is a privately owned biotechnology company focused on the development of lentiviral vector technology for a wide range of therapeutic, vaccine and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, co-developing lentiviral vector-based products across a broad spectrum of bench to clinical applications. Partnerships include The National Institutes of Health, The University of Pennsylvania, ThermoFisher Scientific and The U.S. Army. For further information, visit http://www.lentigen.com/

Contact:

Gregory Tiberend

gtiberend@rlcinc.com

Meghan Feeks

mfeeks@rlcinc.com

Richard Lewis Communications, Inc.

212-827-0020


'/>"/>
SOURCE Lentigen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
2. VIRxSYS and Lentigen Announce Litigation Settlement
3. Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland
4. Emisphere Technologies, Inc. Moves Into New Corporate Headquarters
5. NicOx Opens U.S. Headquarters in New Jersey
6. Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
7. ConforMIS Moves Headquarters to Expanded Facilities in Burlington, MA
8. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
9. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
10. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
11. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
Breaking Biology Technology:
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):